Visiongain Report Offers Transformative Insights on $47bn Rheumatoid Arthritis Market

Friday, January 11, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, January 11, 2019 /PRNewswire/ --

Global Rheumatoid Arthritis Drugs Market Forecast 2019-2029 

Biologics, Non-Biologics, NSAIDs, sDMARDs and Others


The global rheumatoid arthritis drugs market will reach $47bn in 2024. In 2018, the Biologics submarket held 87% of the Global Rheumatoid Arthritis Drugs market.



How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 232-page report you will receive 234 charts- all unavailable elsewhere.

The 232-page report provides clear detailed insight into the rheumatoid arthritis market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope 

Global Rheumatoid Arthritis Market from 2019-2029 

• Forecast of the Global Rheumatoid Arthritis market by Submarket: • Biologics • Non-Biologics: NSAIDs, sDMARDs and Others

• Forecast of the leading drugs in the Global Rheumatoid Arthritis market: • Humira • Enbrel • Remicade • Rituxan/MabThera • Simponi/Simponi Aria • Orencia • Actemra/Roactemra • Cimzia • Celebrex • Xeljanz • Arcoxia • Others

• This report provides individual revenue forecasts to 2029 for these regional and national markets: North America: US, Canada Europe: Germany, France, United Kingdom, Italy, Spain, Russia and rest of Europe Asia-Pacific: Japan, China, India and rest of Asia-Pacific Latin America: Brazil, Mexico, Rest of Latin America Middle East & Africa: Saudi Arabia, South Africa, Rest of MEA

Each regional market is further segmented into Biologics, Non-Biologics, NSAIDs, sDMARDs and Others

• Our study discusses the selected leading companies that are the major players in the rheumatoid arthritis market: • AbbVie • Amgen • AstraZeneca • BMS • Eli Lilly • Johnson & Johnson • Merck & Co • Novartis • Pfizer • Roche • Sanofi • UCB

• Our study discusses selected compounds under development for rheumatoid arthritis.

• This study provides a SWOT and STEP analysis of the rheumatoid arthritis drugs market.

Visiongain's study is intended for anyone requiring commercial analyses for the rheumatoid arthritis market. You find data, trends and predictions.

Buy our report today Global Rheumatoid Arthritis Drugs Market Forecast 2019-2029: Biologics, Non-Biologics, NSAIDs, sDMARDs and Others

To request a report overview of this report please contact Sara Peerun at or refer to our website:

Did you know that we also offer a report add-on service? Email to discuss any customized research needs you may have.

Abbvie Ablynx Abott Laboratories Alder Amgen Astellas Pharma Inc. Baxalta Biocad Biocon Limited Biogen Inc. Bioxpress Therapeutics BMS Boehringer Ingelheim Bristol-Myers Squibb Company Cadila Healthcare Can-Fite Celtrion Chugai Pharmaceutical Co Ltd. Cipla Coherus BioSciences Inc Covagen AG Daiichi Sankyo Dermira, Inc. Dr Reddy's Laboratories Eli Lilly Epirus Biopharmaceuticals F. Hoffmann-La Roche Ltd (Roche) Fujifilm Corporation Fujifilm Kyowa Kirin Galapagos NV Genentech Gerresheimer Gilead Sciences Inc GlaxoSmithKline plc Hanmi Pharmaceutical Hanwha Chemical Hetero Group Hospira IMS Health Incyte Corporation Intas Pharmaceuticals Limited Janseen Biologics Johnson and Johnson LG Life Sciences Lycera Corporation Merck KGaA Mitsubishi Momenta Pharmaceuticals MorphoSys Mycenax Biotech Inc. Mylan N.V. Nichi-Iko Pharmaceutical Novartis Novo Nordisk Oncobiologics Padlock Pfenex Pfizer Protalix Biotherapeutics Regeneron Pharmaceuticals, Inc. Roche Samsung Bioepis Sanofi S.A. Shanghai Celgen Shanghai CP Goujian Pharmaceutical Co Sharp & Dhome Simcere Pharmaceuticals Sun Pharma Takeda Pharmaceuticals Tanabe Pharma Torrent Pharmaceuticals TSH Biopharm UCB Van der Heijde Vitaeris Zydus Cadila Other Organizations Mentioned in This Report African League of Associations in Rheumatology American College of Rheumatology ANVISA (Agência Nacional de Vigilância Sanitária) Arthritis Foundation Bumrungrad Canadian Arthritis Society Centers for Disease Control and Prevention (CDC) Cleveland Clinic Committee for Medicinal Products for Human Use (CHMP) Emirates Arthritis Foundation European Commission European Medicines Agency Government of Abu Dhabi Institut f?r Qualität und Wirtschaftlichkeit im Gesundheitswesen - IQWiG Institute for Quality and Efficiency in Healthcare International League of Associations for Rheumatology Johns Hopkins Ministry of Health National Center for Biotechnology Information National Institute for Health and Care Excellence (NICE) National Institute for Health Research (NIHR) National Institute on Aging National Rheumatoid Arthritis Society National Treasury of Republic of South Africa Nurses Health Servizio Sanitario Nazionale (SSN) U.S. Food and Drug Administration (FDA) Unified Health System United Nations US Patent Office Vamed WHO World Arthritis Day World Bank

To see a report overview please e-mail Sara Peerun on

SOURCE Visiongain

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store